The results of this obesity medication are literally eye-popping. A new review of adverse effects reports to the FDA between the years 2017 and 2024 reveals that Ozempic and Wegovy have both been linked to dozens of cases of ischemic optic neuropathy (ION), or sudden vision loss caused by restricted blood flow to the optic nerve.